Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Grant/Award of 279 KNSA shares, $9.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/Award | 279 | $9.3K |
| Apr 13, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Sale | 6,625 | $309.3K |
| Apr 8, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 3,932 | $3.9K |
| Apr 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/Award | 372 | $9.0K |
| Oct 22, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 791 | $12.3K |
| Oct 8, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 175 | n/a |
| Sep 3, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 2,363 | n/a |
| Aug 6, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/Award | 495 | $7.7K |
| Jun 5, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 15,211 | $235.8K |
| May 9, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 229 | $2.0K |